Carcinoma medular de tiroides metastásico a hígado y pulmón paciente asintomática con enfermedad activa

Autores:
Cabal López, Pablo Daniel
Tipo de recurso:
Article of journal
Fecha de publicación:
2011
Institución:
Fundación Universitaria de Ciencias de la Salud - FUCS
Repositorio:
Repositorio Digital Institucional ReDi
Idioma:
spa
OAI Identifier:
oai:repositorio.fucsalud.edu.co:001/2572
Acceso en línea:
https://repositorio.fucsalud.edu.co/handle/001/2572
https://doi.org/10.31260/RepertMedCir.v20.n2.2011.686
Palabra clave:
carcinoma medular
metástasis
tiroides
calcitonina
antígeno carcinoembrionario
medullary carcinoma
metastases
thyroid gland
calcitonin
carcinoembryonic antigen
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-sa/4.0/
id FUCS2_4f1a848029cd90a0120647f3479ca34d
oai_identifier_str oai:repositorio.fucsalud.edu.co:001/2572
network_acronym_str FUCS2
network_name_str Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv Carcinoma medular de tiroides metastásico a hígado y pulmón paciente asintomática con enfermedad activa
dc.title.translated.eng.fl_str_mv Medullary carcinoma of the thyroid with liver and lung metastases an assymptomatic patient with an active disease
title Carcinoma medular de tiroides metastásico a hígado y pulmón paciente asintomática con enfermedad activa
spellingShingle Carcinoma medular de tiroides metastásico a hígado y pulmón paciente asintomática con enfermedad activa
carcinoma medular
metástasis
tiroides
calcitonina
antígeno carcinoembrionario
medullary carcinoma
metastases
thyroid gland
calcitonin
carcinoembryonic antigen
title_short Carcinoma medular de tiroides metastásico a hígado y pulmón paciente asintomática con enfermedad activa
title_full Carcinoma medular de tiroides metastásico a hígado y pulmón paciente asintomática con enfermedad activa
title_fullStr Carcinoma medular de tiroides metastásico a hígado y pulmón paciente asintomática con enfermedad activa
title_full_unstemmed Carcinoma medular de tiroides metastásico a hígado y pulmón paciente asintomática con enfermedad activa
title_sort Carcinoma medular de tiroides metastásico a hígado y pulmón paciente asintomática con enfermedad activa
dc.creator.fl_str_mv Cabal López, Pablo Daniel
dc.contributor.author.spa.fl_str_mv Cabal López, Pablo Daniel
dc.subject.spa.fl_str_mv carcinoma medular
metástasis
tiroides
calcitonina
antígeno carcinoembrionario
topic carcinoma medular
metástasis
tiroides
calcitonina
antígeno carcinoembrionario
medullary carcinoma
metastases
thyroid gland
calcitonin
carcinoembryonic antigen
dc.subject.eng.fl_str_mv medullary carcinoma
metastases
thyroid gland
calcitonin
carcinoembryonic antigen
publishDate 2011
dc.date.accessioned.none.fl_str_mv 2011-06-01 00:00:00
2022-02-21T20:38:49Z
dc.date.issued.none.fl_str_mv 2011-06-01
dc.date.available.none.fl_str_mv 2011-06-01 00:00:00
2022-02-21T20:38:49Z
dc.type.spa.fl_str_mv Artículo de revista
dc.type.eng.fl_str_mv Journal article
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv Text
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv 10.31260/RepertMedCir.v20.n2.2011.686
dc.identifier.issn.none.fl_str_mv 0121-7372
dc.identifier.uri.none.fl_str_mv https://repositorio.fucsalud.edu.co/handle/001/2572
dc.identifier.eissn.none.fl_str_mv 2462-991X
dc.identifier.url.none.fl_str_mv https://doi.org/10.31260/RepertMedCir.v20.n2.2011.686
identifier_str_mv 10.31260/RepertMedCir.v20.n2.2011.686
0121-7372
2462-991X
url https://repositorio.fucsalud.edu.co/handle/001/2572
https://doi.org/10.31260/RepertMedCir.v20.n2.2011.686
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.references.spa.fl_str_mv Martin-Jean Schlumberger, Sebastiano Filetti Ian O.Hay. Non toxic diffuse and nodular goiter and thyroid neoplasia. Kronenberg: Williams Textbook of Endocrinology, 11th ed. 2008. 2. Lundgren CI, Delbridg L, Learoyd D, Robinson B. Surgical approach to medullary thyroid cancer. Arq Bras Endocrino! Metabol. 2007;51(5):818-24. 3. Kebebew E, ltuarte P H, Siperstein AE, Duh QY, Clark OH. Medullary thyroid carcinoma:clinical characteristics, treatment, prognostic factors, and a comparison ofstaging systems. Cancer. 2000;88(5): 1139-48. 4. AI-Rawi M, Wheeler MH. Medullary tbyroid carcinoma update and present management controversies. Ann R Coll Surg Engl. 2006;88(5):433-8. 5. Bemier JJ, Rambaud JC, Cattan D, Prost A. Diarrhoea associated with medullary carcinoma ofthe thyroid. Gut. 1969;10(12):980-5. 6. Cohen MS, Phay JE, Albinson C et al. Gastrointestinal manifestations of multiple endocrine neoplasia type 2. Ann Surg. 2002;235(5):648-54. 7. Rambaud JC, Jian R, Flourie B et al. Pathophysiological study ofdiarrhoea in a patient with medullary thyroid carcinoma. Evidence against a secretory mechanism and for the role of shortened colonic transit time. Gut. 1988;29(4):537-43. 8. Sand M, Gelos M, Sand D et al. Serum calcitonin negative medullary thyroid carcinoma. World J Surg Oncol. 2006;4:97. 9. Barbet J, Campion L, Kraeber-Bodere F, Chata! JF. Prognostic impact of serum calcitonin andcarcinoembryonicantigen doubling-times in patients with medullary thyroid carcinoma. J Clin Endocrino! Metab. 2005;90(11):6077-84. 10. Chow SM, Chao JK, Tiu SC, Choi KL, Tang DL, Law SC. Medullary thyroid carcinoma in Hong Kong Chinese patients. Hong Kong Med J. 2005;11(4):251-8. 11. Machens A, Hauptmann S, Dralle H. Medullarythyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissem:ination? JClin Endocrino] Metab. 2008;93(6):2234-8. 12. Brandao LG, Cavalheiro BG, Junqueira CR. Prognosticinfluence ofclinical and pathological factorsin medullary thyroid carcinoma: a study of53 cases. Clinics (Sao P aulo). 2009;64(9):849-56. 13. Fromigue J, De BT, Baudio E, Dromain C, Leboulleux S, Schlumberger M. Chemoembolization for liver metastases frommedullary thyroid carcinoma. J Clin Endocrino] Metab. 2006;91(7):2496-9. 14. Schott M, WillenbergHS, Sagert C et al. Identification ofoccult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery. Clin Endocrino! (Oxf). 2007;66(3):405-9. 15. Esik O, Szavcsur P, Szakall S Jr et al. Angiography effectively supports the diagnosis ofhepatic metastases in medullary thyroid carcinoma. Cancer. 2001;91(11):2084-95. 16. Isozaki T, Kiba T, Numata K et al. Medullary thyroid carcinoma with multiple hepatic metastases: treatrnent with transcatheter arterial embolization and percutaneous ethanol injection. Intem Med. 1999;38(1):17-21. 17. Giraudet AL, Vanel D, Leboulleux S et al. Imaging medullary thyroid carcinoma with persisten! elevated calcitonin levels. JClin Endocrino! Metab. 2007;92(11):4185-90. 18. MachensA, Schneyer U, Holzhausen HJ, Dralle H. Prospects ofrem:ission in medullary thyroid carcinoma according to basal calcitonin leve!. J Clin Endocrino! Metab. 2005;90(4):2029-34. 19. Miccoli P, Minuto MN, Ugolini C et al. Clinically unpredictable prognostic factors in the outcome ofmedullary thyroid cancer. Endocr Relat Cancer. 2007;14(4):1099-1105.
dc.relation.bitstream.none.fl_str_mv https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/686/730
dc.relation.citationedition.spa.fl_str_mv Núm. 2 , Año 2011 : Abril – Junio
dc.relation.citationendpage.none.fl_str_mv 127
dc.relation.citationissue.spa.fl_str_mv 2
dc.relation.citationstartpage.none.fl_str_mv 124
dc.relation.citationvolume.spa.fl_str_mv 20
dc.relation.ispartofjournal.spa.fl_str_mv Revista Repertorio de Medicina y Cirugía
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/686
institution Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv https://repositorio.fucsalud.edu.co/bitstreams/b2001ddd-e6cd-4862-839a-5ec6a6a98ede/download
bitstream.checksum.fl_str_mv 2933e3c5583d0f0024ce75f373912e9e
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv redi@fucsalud.edu.co
_version_ 1814355541441380352
spelling Cabal López, Pablo Daniel05d8d8edb65bd2e6b1c032c49a27ebd63002011-06-01 00:00:002022-02-21T20:38:49Z2011-06-012011-06-01 00:00:002022-02-21T20:38:49ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Saludhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/view/686carcinoma medularmetástasistiroidescalcitoninaantígeno carcinoembrionariomedullary carcinomametastasesthyroid glandcalcitonincarcinoembryonic antigenCarcinoma medular de tiroides metastásico a hígado y pulmón paciente asintomática con enfermedad activaMedullary carcinoma of the thyroid with liver and lung metastases an assymptomatic patient with an active diseaseapplication/pdfArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.v20.n2.2011.6860121-7372https://repositorio.fucsalud.edu.co/handle/001/25722462-991Xhttps://doi.org/10.31260/RepertMedCir.v20.n2.2011.686spaMartin-Jean Schlumberger, Sebastiano Filetti Ian O.Hay. Non toxic diffuse and nodular goiter and thyroid neoplasia. Kronenberg: Williams Textbook of Endocrinology, 11th ed. 2008. 2. Lundgren CI, Delbridg L, Learoyd D, Robinson B. Surgical approach to medullary thyroid cancer. Arq Bras Endocrino! Metabol. 2007;51(5):818-24. 3. Kebebew E, ltuarte P H, Siperstein AE, Duh QY, Clark OH. Medullary thyroid carcinoma:clinical characteristics, treatment, prognostic factors, and a comparison ofstaging systems. Cancer. 2000;88(5): 1139-48. 4. AI-Rawi M, Wheeler MH. Medullary tbyroid carcinoma update and present management controversies. Ann R Coll Surg Engl. 2006;88(5):433-8. 5. Bemier JJ, Rambaud JC, Cattan D, Prost A. Diarrhoea associated with medullary carcinoma ofthe thyroid. Gut. 1969;10(12):980-5. 6. Cohen MS, Phay JE, Albinson C et al. Gastrointestinal manifestations of multiple endocrine neoplasia type 2. Ann Surg. 2002;235(5):648-54. 7. Rambaud JC, Jian R, Flourie B et al. Pathophysiological study ofdiarrhoea in a patient with medullary thyroid carcinoma. Evidence against a secretory mechanism and for the role of shortened colonic transit time. Gut. 1988;29(4):537-43. 8. Sand M, Gelos M, Sand D et al. Serum calcitonin negative medullary thyroid carcinoma. World J Surg Oncol. 2006;4:97. 9. Barbet J, Campion L, Kraeber-Bodere F, Chata! JF. Prognostic impact of serum calcitonin andcarcinoembryonicantigen doubling-times in patients with medullary thyroid carcinoma. J Clin Endocrino! Metab. 2005;90(11):6077-84. 10. Chow SM, Chao JK, Tiu SC, Choi KL, Tang DL, Law SC. Medullary thyroid carcinoma in Hong Kong Chinese patients. Hong Kong Med J. 2005;11(4):251-8. 11. Machens A, Hauptmann S, Dralle H. Medullarythyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissem:ination? JClin Endocrino] Metab. 2008;93(6):2234-8. 12. Brandao LG, Cavalheiro BG, Junqueira CR. Prognosticinfluence ofclinical and pathological factorsin medullary thyroid carcinoma: a study of53 cases. Clinics (Sao P aulo). 2009;64(9):849-56. 13. Fromigue J, De BT, Baudio E, Dromain C, Leboulleux S, Schlumberger M. Chemoembolization for liver metastases frommedullary thyroid carcinoma. J Clin Endocrino] Metab. 2006;91(7):2496-9. 14. Schott M, WillenbergHS, Sagert C et al. Identification ofoccult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery. Clin Endocrino! (Oxf). 2007;66(3):405-9. 15. Esik O, Szavcsur P, Szakall S Jr et al. Angiography effectively supports the diagnosis ofhepatic metastases in medullary thyroid carcinoma. Cancer. 2001;91(11):2084-95. 16. Isozaki T, Kiba T, Numata K et al. Medullary thyroid carcinoma with multiple hepatic metastases: treatrnent with transcatheter arterial embolization and percutaneous ethanol injection. Intem Med. 1999;38(1):17-21. 17. Giraudet AL, Vanel D, Leboulleux S et al. Imaging medullary thyroid carcinoma with persisten! elevated calcitonin levels. JClin Endocrino! Metab. 2007;92(11):4185-90. 18. MachensA, Schneyer U, Holzhausen HJ, Dralle H. Prospects ofrem:ission in medullary thyroid carcinoma according to basal calcitonin leve!. J Clin Endocrino! Metab. 2005;90(4):2029-34. 19. Miccoli P, Minuto MN, Ugolini C et al. Clinically unpredictable prognostic factors in the outcome ofmedullary thyroid cancer. Endocr Relat Cancer. 2007;14(4):1099-1105.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/686/730Núm. 2 , Año 2011 : Abril – Junio127212420Revista Repertorio de Medicina y Cirugíainfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2PublicationOREORE.xmltext/xml2590https://repositorio.fucsalud.edu.co/bitstreams/b2001ddd-e6cd-4862-839a-5ec6a6a98ede/download2933e3c5583d0f0024ce75f373912e9eMD51001/2572oai:repositorio.fucsalud.edu.co:001/25722024-02-02 13:07:05.352https://creativecommons.org/licenses/by-nc-sa/4.0/metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co

Publicaciones similares